First Description of Marinoquinoline Derivatives' Activity against <i>Toxoplasma gondii</i>.

Journal Information

Full Title: Pharmaceutics

Abbreviation: Pharmaceutics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results."

Evidence found in paper:

"This research received financial support from the São Paulo Research Foundation (FAPESP) (grant numbers 2018/18954-4 and 2020/03399-5 to J.Q.R., and 2014/25770-6, 2014/07600-3, and 2023/00383-9 to C.R.D.C.) and the Brazilian National Research Council (CNPq) (grant numbers 406643/2018-0 and 306773/2018-0 to C.R.D.C.). Scholarships from CNPq supported A.B.S.B.R. (161711/2021-9), B.I.T. (136293/2019-0), and R.D.d.E.S. (405568/2017-7). L.T.H.D. received a scholarship from the Coordination for the Improvement of Higher Education Personnel (CAPES), R.D.d.E.S. received a scholarship from FAPESP (2017/11316-0), R.P.B.d.M. received a scholarship from the Paraíba Research Foundation (FAPESQ) (grant number 2002/2022), and G.B.d.L. received a scholarship from the Institutional Scientific Initiation Program of the Faculty of Medicine of Jundiaí (PIBIC/FMJ)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025